SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-014083
Filing Date
2022-05-12
Accepted
2022-05-12 16:14:40
Documents
17
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20220512.htm   iXBRL 8-K 34311
2 EX-99.1 exhibit991_051222pressrele.htm EX-99.1 25311
7 GRAPHIC bs_mar22a.jpg GRAPHIC 93801
8 GRAPHIC is_q222a.jpg GRAPHIC 61577
9 GRAPHIC logo.jpg GRAPHIC 9327
  Complete submission text file 0001628280-22-014083.txt   464854

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20220512.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20220512_def.xml EX-101.DEF 14938
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20220512_lab.xml EX-101.LAB 28848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20220512_pre.xml EX-101.PRE 15535
11 EXTRACTED XBRL INSTANCE DOCUMENT advm-20220512_htm.xml XML 12887
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 22917971
SIC: 2836 Biological Products, (No Diagnostic Substances)